Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16341180 | 0.83 | ALDH1A1 (0.34) | ALDH1A1TSHRMAPK1KDM4ESMN1; SMN2 | |
| SCHEMBL16341255 | 0.79 | FAAH (0.39) | ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL16341474 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TSHRMAPK1KDM4ESMN1; SMN2 | |
| SCHEMBL16341021 | 0.79 | — | — | |
| SCHEMBL3865966 | 0.72 | — | — | |
| SCHEMBL2864735 | 0.70 | TDP1 (0.40) | ALDH1A1TSHR | |
| SCHEMBL343124 | 0.70 | — | — | |
| SCHEMBL14370458 | 0.70 | ALDH1A1 (0.45) | ALDH1A1TSHR | |
| SCHEMBL11671380 | 0.69 | ALDH1A1 (0.42) | ALDH1A1TSHRMAPK1KDM4ESMN1; SMN2 | |
| Hydrogen Sulfide SCHEMBL28099743 | 0.69 | ALDH1A1 (0.43) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9775371-B2 | Decanoic acid derivatives and flavoring compositions | T. HASEGAWA CO., LTD. (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20140377434-A1 | NOVEL DECANOIC ACID DERIVATIVES AND FLAVORING COMPOSITIONS | T. HASEGAWA CO., LTD. (JP) | 2014-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140377434-A1 | NOVEL DECANOIC ACID DERIVATIVES AND FLAVORING COMPOSITIONS | TAS2R5, FFAR3, FFAR1 | ALDH1A1 525/4885TSHR 2436/4885MAPK1 2224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.